No Data
Delta-Fly Pharma: 3Q financial results presentation materials for the fiscal year ending 2025/3 20250214
Delta-Fly Pharma Sees Parent FY Loss Y1.83B
Delta-Fly Pharma: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Kirin HD, Matsukiyo Cocok, Dentsu Group, Rakuten Group (14th) (1379-5368)
The above Calendar is merely a schedule and is subject to change due to the company's circumstances.--------------------------------------- February 14 (Friday) <1379> Hokuto <1380> Akigawa Boku-en <1417> Mirait-Wan <142A> Jinjibu <1438> Gifu Landscaping <1443> Giken HD <1447> SAAF HD <145A> Elizbee<
The shareholding ratio of DeltaF and Macquarie Bank has increased to 6.79%.
It has been revealed that Macquarie Bank's Shareholding in DeltaF<4598.T> has increased. According to a large Shareholding change report submitted by Macquarie Bank after the market closed on January 31, the Shareholding percentage has risen from 5.33% to 6.79% since the last submission. The purpose of the Shareholding is pure investment. The closing price on January 31 was 538 yen, down 12 yen from the previous day. Provided by Wealth Advisor Company.
Express News | [Change Report] Australia’s Macquarie Silver reports an increase in shareholding of Delta-Fly Pharma (4598.JP) to 6.79%.